Advs. Micki Shapira, Daniel Green and Sophy Litvin represented Fosun Health Fund (the venture capital arm of Fosun Pharma) in an exclusive license and supply agreement with Raziel Therapeutics to develop and commercialize Raziel's proprietary RZL-012, an injection used for reducing double chins, in mainland China, Hong Kong, Macau, and Taiwan for milestone payments of up to $74 million plus tiered royalties on future sales. The team was joined by advs. Miriam Friedmann, Inbar Hakimian-Nahari and intern Yang Cheng.
Barak Platt and Josh Hauser represented Intel Capital in leading a $17 million Series A investment in SWIR (short-wave-infra-red) sensing technology developer TriEye.
Our firm represented Super-Pharm in the sale of %33 of its shares, held by Leumi Partners, Discount Capital and Leon Koffler, to Union Group (official importer of for Toyota and H&M in Israel), for a total of NIS 600 million. Super-Pharm is represented by Gidon Weinstock, Micki Shapira, Asaf Messica, Ofir Levy, Shira Lahat, Noa Slavin, Igor Baraz, Amit Zomer-Fedida, Shay Fahima, Ophir Dagan and Noa Bombigher.
Magisto is represented by Barak Platt, Daniel Damboritz, Ezra Gross, Eli Greenbaum, Dr. Eran Lempert, Josh Hauser, Miriam Friedmann and Shay Fahima.